Esperion Therapeutics Inc... (ESPR)

NASDAQ: ESPR · Real-Time Price · USD

0.98

-0.02 (-1.94%)

At close: May 01, 2025, 3:59 PM

1.00

2.04%

Pre-market: May 02, 2025, 07:00 AM EDT

Esperion Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-51.74M	-209.25M	-233.66M	-269.11M	-143.55M	-97.17M	-201.81M	-166.99M	-74.98M
Depreciation & Amortization	63K	164K	500K	612K	547K	319K	265K	258K	252K
Stock-Based Compensation	11.99M	11.96M	15.21M	24.31M	28.39M	25.88M	23.97M	18.61M	15.96M
Other Working Capital	n/a	50.18M	2.63M	10.39M	-490K	8.76M	4.71M	708K	6.09M
Other Non-Cash Items	16.04M	47.96M	46.49M	35.53M	33.8M	8.12M	-217K	23K	44K
Deferred Income Tax	n/a	n/a	n/a	-2.63M	-97K	-200K	n/a	334K	1.01M
Change in Working Capital	n/a	13.68M	-3.37M	-52.51M	-4.26M	-7.3M	29.16M	16.47M	9.98M
Operating Cash Flow	-23.65M	-135.49M	-174.83M	-263.81M	-85.18M	-70.34M	-148.64M	-131.3M	-47.73M
Capital Expenditures	-317K	n/a	n/a	n/a	-13.37M	-953K	-151K	-19K	-94K
Cash Acquisitions	n/a	n/a	n/a	n/a	12.5M	-65.18M	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-59.9M	-50.48M	-4.42M	-34.33M	-25.48M	-219.58M	-197.23M
Sales Maturities Of Investments	n/a	42.5M	68M	n/a	39.15M	99.51M	166.08M	183.74M	207.44M
Other Investing Acitivies	n/a	n/a	8.1M	-50.48M	-12.5M	65.18M	140.6M	-35.83M	10.21M
Investing Cash Flow	-317K	42.5M	8.1M	-50.48M	21.36M	64.23M	140.45M	-35.85M	10.12M
Debt Repayment	35.01M	n/a	n/a	n/a	271.6M	n/a	-1.05M	-1.71M	-1.6M
Common Stock Repurchased	n/a	n/a	n/a	n/a	-55M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-39.72M	-6.42M	-58.24M	49.53M	-14.87M	136.19M	11.74M	1.17M	45K
Financial Cash Flow	86.48M	50.46M	32.61M	268.22M	201.72M	136.19M	10.69M	163.46M	-1.56M
Net Cash Flow	62.51M	-42.53M	-134.12M	-46.07M	137.9M	130.09M	2.5M	-3.7M	-39.17M
Free Cash Flow	-23.97M	-135.49M	-174.83M	-263.81M	-98.55M	-71.29M	-148.79M	-131.32M	-47.82M